Clinical Trials
34 trialsNCT07589101 2026-05-15
5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Phase NA Not yet recruiting
NCT04119024 2026-03-17
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Phase 1 Recruiting
NCT05775939 2026-02-10
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
Thomas Jefferson University
Phase NA Recruiting
NCT07293247 2025-12-22
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Alliance for Clinical Trials in Oncology
Phase 2 Not yet recruiting
NCT04147494 2025-08-12
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT07118176 2025-08-12
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Jonsson Comprehensive Cancer Center
Phase 1 Recruiting
NCT05463913 2025-03-07
Lung Nodule Detection Using Ultra-long FOV PET/CT
University Medical Center Groningen
Phase 4 Recruiting
NCT05501665 2024-10-17
Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer
Vanderbilt-Ingram Cancer Center
Phase 1/2 Recruiting
NCT02773238 2024-08-14
FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging
University of Washington
Phase 2 Completed
NCT05543954 2024-07-05
68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Recruiting
NCT03493789 2023-10-18
Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy
Emory University
Phase 1 Completed
NCT05840094 2023-05-03
Multimodalitic Imaging in the N-stage of Lung Cancer
Peking University First Hospital
Phase NA Unknown
NCT05803746 2023-04-07
PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid Tumor
Peking University Cancer Hospital & Institute
Phase NA Unknown
NCT02448225 2022-10-19
18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
Vanderbilt-Ingram Cancer Center
Phase 2 Completed
NCT00450567 2020-08-03
Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy
Jonsson Comprehensive Cancer Center
Completed
NCT01806675 2019-10-03
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
Stanford University
Phase 1/2 Completed
NCT01666353 2019-02-08
PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Completed
NCT02599194 2019-01-03
18F-FSPG PET/CT for Cancer Patients on Therapy
Stanford University
Phase 2 Completed
NCT01789892 2018-06-28
Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer
Ohio State University Comprehensive Cancer Center
Phase NA Withdrawn
NCT00852644 2018-05-11
Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
Boston Medical Center
Phase NA Terminated
NCT00732563 2017-10-18
Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery
Roswell Park Cancer Institute
Phase NA Completed
NCT00227539 2017-05-09
Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
University of Washington
Phase 2 Completed
NCT00564733 2017-02-10
FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
University of Washington
Phase 2 Completed
NCT02059889 2016-12-16
Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer
Virginia Commonwealth University
Phase NA Withdrawn
NCT02938546 2016-10-21
18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study
Shanghai Chest Hospital
Phase 3 Unknown
NCT00004138 2016-07-13
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Phase NA Completed
NCT01172041 2016-07-01
The Role of Audiovisual Biofeedback on Image Quality During 4D Anatomic and Functional Imaging
Stanford University
Completed
NCT02481726 2015-06-25
68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT
Xijing Hospital
Phase 1/2 Completed
NCT00765986 2014-10-03
Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy
AHS Cancer Control Alberta
Unknown
NCT00002930 2013-01-18
PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery
Memorial Sloan Kettering Cancer Center
Phase 2/3 Completed
NCT01017133 2012-09-26
Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT01314677 2012-06-29
Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation
City of Hope Medical Center
Phase NA Withdrawn
NCT00253461 2012-03-20
11C Topotecan PET Imaging
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT00522639 2009-06-30
FDG-PET lung
Maastricht Radiation Oncology
Phase 3 Terminated